Vape-Free Text-Messaging: Pilot Study
Text-messaging E-cigarette Cessation Intervention for Young Adults in Rural Areas: A Pilot Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53211
- Recruiting
- University of Wisconsin-Milwaukee
-
Contact:
- Seok Hyun Gwon, PhD, RN
- Phone Number: 4142296462
- Email: gwon@uwm.edu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- English speaking
- 18-24 years
- everyday e-cigarette use in the past month
- ownership of a mobile phone or smartphone with texting and internet access abilities
- knowledge of how to use text messages
- plan on quitting e-cigarette use within one month
- home address in a rural county of Wisconsin, Minnesota, North Dakota, and South Dakota
Exclusion Criteria:
- Individuals who reported use of other tobacco products (e.g., cigarettes, smokeless tobacco) than e-cigarettes in the past month
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Intervention (E-cigarette cessation text-messaging intervention)
|
This is the intervention for e-cigarette cessation using text messages targeting young adults in rural areas.
|
|
Active Comparator: Standard care (Standard care control using standard national resources)
This standard care group will receive standard care resources from smokefree.gov.
|
This is the standard care with national resources from smokefree.gov.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants recruited and randomized
Time Frame: Throughout 12 months
|
Number of participants recruited and randomized
|
Throughout 12 months
|
|
Self-reported proportion of text messages read
Time Frame: At 1 month
|
Proportion of text messages read during the intervention or standard care at 1 month
|
At 1 month
|
|
Retention rates (proportion of participants remained until 1 month post-intervention from enrollment)
Time Frame: At 1 month
|
Proportion of participants from enrollment to 1 month post-intervention or standard-care
|
At 1 month
|
|
Level of acceptability of the intervention
Time Frame: At 1 month
|
|
At 1 month
|
|
Proportion of salivary cotinine samples returned
Time Frame: At 1 month
|
Proportion of salivary cotinine samples returned to the office lab for cotinine analysis
|
At 1 month
|
|
Self-reported 7-days point prevalence abstinence from ENDS and other tobacco
Time Frame: At 1 month
|
Self-reported 7-days point prevalence abstinence from ENDS and other tobacco
|
At 1 month
|
|
Concentration of cotinine in saliva
Time Frame: At 1 month
|
Biochemically verified abstinence evaluated by salivary cotinine samples
|
At 1 month
|
|
Nicotine dependence (Penn State Electronic Cigarette Dependence Index)
Time Frame: At 1 month
|
Nicotine dependence (minimum 0 to maximum 20, higher scores mean a worse outcome.)
|
At 1 month
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 23.179
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.